138 citations
- Friedrich-Alexander-Universität Erlangen-NürnbergDE7 papers
- Technical University of MunichDE6 papers
- Centre National de la Recherche ScientifiqueFR5 papers
- University of BristolGB5 papers
- Ludwig-Maximilians-Universität MünchenDE4 papers
- Boehringer Ingelheim (Germany)DE3 papers
- Bristol Robotics LaboratoryGB3 papers
- ESPCI ParisFR3 papers
- GulliverFR3 papers
- Max Planck Institute for the Science of LightDE3 papers
- Merck KGaA, Darmstadt (Germany)DE3 papers
- Monash UniversityAU3 papers
Showing stat.APShow all
3 papers · 1 filter
stat.AP2022★ 88 cited
The use of external controls: To what extent can it currently be recommended?
Hans Ulrich Burger, Christoph Gerlinger, Chris Harbron +4
With more and better clinical data being captured outside of clinical studies and greater data sharing of clinical studies, external controls may become a more attractive alternati…
stat.AP2020★ 28 cited
Survival analysis for AdVerse events with VarYing follow-up times (SAVVY) -- estimation of adverse event risks
Regina Stegherr, Claudia Schmoor, Jan Beyersmann +12
The SAVVY project aims to improve the analyses of adverse event (AE) data in clinical trials through the use of survival techniques appropriately dealing with varying follow-up tim…
stat.AP2020★ 4 cited
Survival analysis for AdVerse events with VarYing follow-up times (SAVVY) -- comparison of adverse event risks in randomized controlled trials
Kaspar Rufibach, Regina Stegherr, Claudia Schmoor +12
Analyses of adverse events (AEs) are an important aspect of the evaluation of experimental therapies. The SAVVY (Survival analysis for AdVerse events with Varying follow-up times)…